Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
Status:
Terminated
Trial end date:
2002-12-28
Target enrollment:
Participant gender:
Summary
RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the
laboratory. Antineoplastons may inhibit the growth of cancer cells.
PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating
women who have stage IV breast cancer that has not responded to previous therapy.